The table below shows Zymeworks Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Operating cash flow
-$45.72M
-$3.41M
-$37.67M
-$83.19M
-$55.41M
Capital expenditure
$216.00K
$16.00K
$185.00K
$386.00K
$4.16M
Investing cash flow
$69.96M
$12.18M
-$7.32M
-$138.22M
$20.57M
Dividends paid
-
-
-
-
-
Stock buybacks
$76.15M
ZYME operating cash flow (10-K history)
Zymeworks Inc. reported operating cash flow of -$33.01M for fiscal year 2025. That is up 70.0% from -$110.06M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow grew from -$151.40M (FY 2020) to -$33.01M. Figures come from the company's audited annual reports as filed with the SEC.
